Viewing StudyNCT00353587



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00353587
Status: COMPLETED
Last Update Posted: 2015-05-01
First Post: 2006-07-14

Brief Title: Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
Sponsor: CymaBay Therapeutics Inc
Organization: CymaBay Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes
Keywords:
Name View
glucose control View
insulin sensitizer View
type 2 diabetes View
diabetes View